To impose sanctions with respect to Chinese producers of synthetic opioids and opioid precursors, to hold Chinese officials accountable for the spread of illicit fentanyl, and for other purposes.

Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Bill 119 HR 747, also known as the "Chinese Opioid Sanctions Act," aims to address the growing crisis of synthetic opioids and opioid precursors originating from China. The bill proposes imposing sanctions on Chinese producers of these dangerous substances in an effort to combat the spread of illicit fentanyl in the United States.

The primary goal of the bill is to hold Chinese officials accountable for their role in the production and distribution of synthetic opioids, which have contributed to the opioid epidemic in the US. By targeting these producers with sanctions, the bill seeks to disrupt the supply chain of these deadly drugs and prevent further harm to American communities.

In addition to imposing sanctions, the bill also includes provisions for increased cooperation and information sharing between US and Chinese law enforcement agencies to combat the illicit drug trade. This collaboration is crucial in addressing the transnational nature of the opioid crisis and ensuring that those responsible for producing and trafficking these substances are held accountable. Overall, Bill 119 HR 747 represents a bipartisan effort to address the devastating impact of synthetic opioids on American society. By targeting Chinese producers and officials involved in the spread of illicit fentanyl, the bill aims to stem the flow of these dangerous substances and protect the health and safety of the American people.